BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 ,inter alia, to consider and approve 1) To consider and approve the Un-Audited Financial Results along with Statements of Assets and Liabilities and Cash Flow Statement of the Company for the Quarter and half year ended 30th September, 2023.\r\n\r\n2) Other routine business with the permission of the Chair.\r\n